Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Medikaloka Hermina TbkISX:HEAL +2.31%68 ROC (Joel Greenblatt) % is 9.31% as of Jun. 2026, which is 47% below its 10-year median of 17.72. GuruFocus rates ISX:HEAL with a GF Score™ of 68/100 and a GF Value™ of Rp1,571.56 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 675 Healthcare Providers & Services companies, PT Medikaloka Hermina Tbk ranks worse than 52.44% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. PT Medikaloka Hermina Tbk's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 9.31%.
The historical rank and industry rank for PT Medikaloka Hermina Tbk's ROC (Joel Greenblatt) % or its related term are showing as below:
ISX:HEAL'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 10.31 Med: 17.72 Max: 40.48
Current: 10.31
During the past 11 years, PT Medikaloka Hermina Tbk's highest ROC (Joel Greenblatt) % was 40.48%. The lowest was 10.31%. And the median was 17.72%.
ISX:HEAL's ROC (Joel Greenblatt) % is ranked worse than 52.44% of 675
companies
in the Healthcare Providers & Services industry
Industry Median: 12.31
vs ISX:HEAL: 10.31
PT Medikaloka Hermina Tbk's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -19.50% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
PT Medikaloka Hermina Tbk ROC (Joel Greenblatt) % Related Terms
PT Medikaloka Hermina Tbk ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for PT Medikaloka Hermina Tbk's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:HEAL vs HCA, THC, EHC: ROC (Joel Greenblatt) % Comparison
For the Medical Care Facilities subindustry, PT Medikaloka Hermina Tbk's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Medikaloka Hermina Tbk ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Medikaloka Hermina Tbk's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where PT Medikaloka Hermina Tbk's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 9.31% mean?
PT Medikaloka Hermina Tbk (ISX:HEAL) has a ROC (Joel Greenblatt) % of 9.31% as of Jun. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on PT Medikaloka Hermina Tbk and its competitors. This is 47% below median its historical median of 17.72. Over the past decade, PT Medikaloka Hermina Tbk's ROC (Joel Greenblatt) % has ranged from 10.31 to 40.48. According to the industry distribution chart, PT Medikaloka Hermina Tbk ranks #354 out of 675 companies in the Healthcare Providers & Services industry, placing it in the top 52.4%.
Is PT Medikaloka Hermina Tbk's ROC (Joel Greenblatt) % too high?
PT Medikaloka Hermina Tbk's current ROC (Joel Greenblatt) % of 9.31% is 47% below median its 10-year median of 17.72. Over the past 10 years, this metric has ranged from a low of 10.31 to a high of 40.48. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.31. PT Medikaloka Hermina Tbk's value of 9.31% is 24.4% below this industry median. Based on the distribution chart, PT Medikaloka Hermina Tbk ranks #354 out of 675 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PT Medikaloka Hermina Tbk has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Medikaloka Hermina Tbk's ROC (Joel Greenblatt) % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Medikaloka Hermina Tbk ranks #354 out of 675 companies for ROC (Joel Greenblatt) %. This places PT Medikaloka Hermina Tbk in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 12.31. PT Medikaloka Hermina Tbk's value of 9.31% is 24.4% below this benchmark. Historically, PT Medikaloka Hermina Tbk's own ROC (Joel Greenblatt) % has ranged from 10.31 to 40.48 over the past decade. While the company's 10-year median is 17.72 vs. the industry median of 12.31, PT Medikaloka Hermina Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.31, based on 675 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Medikaloka Hermina Tbk's current ROC (Joel Greenblatt) % of 9.31% is 24.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on PT Medikaloka Hermina Tbk and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Medikaloka Hermina Tbk's current ROC (Joel Greenblatt) % is 9.31%, which is 47% below median its own 10-year median of 17.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medikaloka Hermina Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk (ISX:HEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,571.56, compared to a current price of Rp665.00 — trading 57.7% below its estimated fair value. The current ROC (Joel Greenblatt) % is 9.31%, which is 47% below median its 10-year median of 17.72 and 24.4% below the Healthcare Providers & Services industry median of 12.31. PT Medikaloka Hermina Tbk's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For PT Medikaloka Hermina Tbk (ISX:HEAL), the current ROC (Joel Greenblatt) % is 9.31% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Medikaloka Hermina Tbk (ISX:HEAL) Overvalued in 2026?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk stock appears to be undervalued.
The current stock price of Rp665.00 is trading 57.7% below its estimated GF Value™ of Rp1,571.56.
GuruFocus considers PT Medikaloka Hermina Tbk to be Significantly Undervalued.
Key valuation signals for ISX:HEAL:
ROC (Joel Greenblatt) %: 9.31% (47% below median its 10-year median of 17.72)
GF Value™: Rp1,571.56 vs. price of Rp665.00 (57.7% below fair value)
Industry Position: 24.4% below the Healthcare Providers & Services median (#354 of 675)
No single metric tells the full story. See the ISX:HEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
68GF Score
Get the complete analysis for ISX:HEAL
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:HEAL has been successfully added to your 
